Item 9 Labs Corp INLB
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 102.36M
- Market Cap
- $102.36
- Volume/Avg
- 350 / 12,939
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Item 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The Item 9 Labs brand specializes in products and user experience across several cannabis categories. The company also offers a dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. The company also brings industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 104
- Website
- https://www.item9labscorp.com
Valuation
|
Metric
|
INLB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
INLB
Financial Strength
|
Metric
|
INLB
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.06 |
Interest Coverage | −2.37 |
Quick Ratio
INLB
Profitability
|
Metric
|
INLB
|
|---|---|
Return on Assets (Normalized) | −16.83% |
Return on Equity (Normalized) | −30.95% |
Return on Invested Capital (Normalized) | −12.76% |
Return on Assets
INLB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!zNXFL! | LOCK|#d%R | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|#bfX#Qp | LOCK|k^M@ | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|lz<%@K$ | LOCK|!Y& | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|<^J$^?>B | LOCK|$&$ | $33B | |||
| Viatris Inc
VTRS
| LOCK|JJ@zzxR | LOCK|n<% | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|y$S | LOCK|P?N | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|YDC&KF | LOCK|k# | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|<pZV&$$ | LOCK|cLc | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!>@Xw% | LOCK|Q$<c | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Q%KC?Lr | LOCK|GT< | $2B |
United States